Patents by Inventor Michael Noto

Michael Noto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10826927
    Abstract: Systems and methods for detecting anomalous data traffic over proxy servers in a data communications network. The method includes receiving, by a server computing device, network log data corresponding to data traffic during a timeframe. The method further includes normalizing the network log data using at least one of timestamp data of the network log data or IP address data of the network log data. The method also includes extracting risk-based data features from the network log data. The method further includes calculating using an isolation forest algorithm, anomaly scores for the normalized network log data based on the extracted risk-based features. The method also includes determining at least one anomaly event based on the calculated anomaly scores. The method further includes identifying at least one host device and at least one timestamp corresponding to the at least one anomaly event.
    Type: Grant
    Filed: March 5, 2020
    Date of Patent: November 3, 2020
    Assignee: FMR LLC
    Inventors: Amin Assareh, Charles Voelker, Peter Theodoros, Joshua Marine, Michael Noto
  • Patent number: 10538733
    Abstract: A cell, isolated nucleic acid, vector, isolated polypeptide, and method of treating a bacterial infection are provided. The cell includes a modified Acinetobacter baumannii cell having a mutation in an A. baumannii gene selected from a mutation that occurs when generating mutations in A. baumanni using transposon mutagenesis. The isolated nucleic acid includes a sequence expressing a lpsB, mffT, or GctA polypeptide comprising at least one nucleic acid mutation. The vector includes the isolated nucleic acid. The isolated polypeptide includes a lpsB, mffT, or GctA polypeptide comprising at least one nucleic acid mutation. The method of treating a bacterial infection includes administering to a subject an effective amount of an Acinetobacter baumannii composition including modified Acinetobacter baumannii cell.
    Type: Grant
    Filed: June 29, 2018
    Date of Patent: January 21, 2020
    Assignee: Vanderbilt University
    Inventors: Eric P. Skaar, M. Indriati Hood, Michael Noto
  • Publication number: 20180305659
    Abstract: A cell, isolated nucleic acid, vector, isolated polypeptide, and method of treating a bacterial infection are provided. The cell includes a modified Acinetobacter baumannii cell having a mutation in an A. baumannii gene selected from a mutation that occurs when generating mutations in A. baumanni using transposon mutagenesis. The isolated nucleic acid includes a sequence expressing a lpsB, mffT, or GctA polypeptide comprising at least one nucleic acid mutation. The vector includes the isolated nucleic acid. The isolated polypeptide includes a lpsB, mffT, or GctA polypeptide comprising at least one nucleic acid mutation. The method of treating a bacterial infection includes administering to a subject an effective amount of an Acinetobacter baumannii composition including modified Acinetobacter baumannii cell.
    Type: Application
    Filed: June 29, 2018
    Publication date: October 25, 2018
    Inventors: Eric P. Skaar, M. Indriati Hood, Michael Noto
  • Publication number: 20160324951
    Abstract: A cell, isolated nucleic acid, vector, isolated polypeptide, and method of treating a bacterial infection are provided. The cell includes a modified Acinetobacter baumannii cell having a mutation in an A. baumannii gene selected from a mutation that occurs when generating mutations in A. baumannii using transposon mutagenesis. The isolated nucleic acid includes a sequence expressing a lpsB, mffT, or GctA polypeptide comprising at least one nucleic acid mutation. The vector includes the isolated nucleic acid. The isolated polypeptide includes a lpsB, mffT, or GctA polypeptide comprising at least one nucleic acid mutation. The method of treating a bacterial infection includes administering to a subject an effective amount of an Acinetobacter baumannii composition including modified Acinetobacter baumannii cell.
    Type: Application
    Filed: May 5, 2016
    Publication date: November 10, 2016
    Inventors: Eric P. Skaar, M. Indriati Hood, Michael Noto